ColoSeal Intraluminal Colonic Diversion (ICD) System Anastomotic Protection Pivotal Study

Clinical Trial Information

Trial Phone: 321-841-7246

Principal Investigator: Marco Ferrara, MD

Phase: N/A

Age Group: ADULTOLDER_ADULT

ClinicalTrials.gov ID: NCT07429110

Objective

The purpose of this clinical investigation is to compare the outcomes and safety of utilizing the ColoSeal ICD System compared to current standard of care for rectal cancer surgery.

Share:

Related Clinical Trials

An Interventional Phase Ib/II Study to Evaluate the Safety and Efficacy of PF-08634404 Monotherapy and in Combination with Other Anticancer Agents in Adult Participants with Locally Advanced or Metastatic Renal Cell Carcinoma
Percutaneous or Endoscopic Gallbladder Drainage: The PEG Trial
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL GROUP, MULTICENTER STUDY WITH OPEN-LABEL EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF FENFLURAMINE HYDROCHLORIDE IN STUDY PARTICIPANTS WITH RETT SYNDROME
A Phase III, Randomized, Open-Label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (sac-TMT, MK-2870) as a Monotherapy and in Combination with Pembrolizumab (MK-3475) versus Treatment of Physicians Choice in Participants with Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD L1 at CPS Less than 10 (TroFuse-11)